Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MURPHY, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MURPHY, J. D.
(Chest. 1957;31:658-664.)
© 1957 American College of Chest Physicians

The Management of Tuberculous Empyema

JAMES D. MURPHY M.D., F.C.C.P.1

1 VA Hospital, Oteen, North Carolina., Manager, VA Hospital, Baltimore, Maryland.

In 1931 a Committee Report on the Treatment of Tuberculous Empyema was submitted by Leroy S. Peters, Paul Ringer, J. J. Singer, and E. S. Welles. Among other conclusions were these:

1. Most tuberculous empyemata are best treated by no treatment.

2. Aspiration is justified to relieve high fever and pressure symptoms.

3. Closed or open drainage is not warranted since it converts a simple empyema into a pyogenic one.

In the years following that report and before the advent of successful chemotherapy, considerable reduction in mortality had been brought about by the more frequent use of thoracoplasty with or without preliminary drainage.

The demonstration of the bacteriostatic effect of streptomycin in 1946 opened the door for further improvements in the management of tuberculous empyema.

Active treatment has replaced inactivity. As soon as a diagnosis is established a carefully formulated program is set in motion with the objectives of elimination of toxicity, stabilization of the disease process and obliteration of the empyema space. These goals may occasionally be accomplished with chemotherapy and thoracentesis. Most commonly, however, chemotherapy accompanied by drainage, decortication, thoracoplasty, or resection is required.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1957 by the American College of Chest Physicians.